Impact of malaria at the end of pregnancy on infant mortality and morbidity

Azucena Bardají, Betuel Sigauque, Sergi Sanz, María Maixenchs, Jaume Ordi, John J Aponte, Samuel Mabunda, Pedro L Alonso, Clara Menéndez, Azucena Bardají, Betuel Sigauque, Sergi Sanz, María Maixenchs, Jaume Ordi, John J Aponte, Samuel Mabunda, Pedro L Alonso, Clara Menéndez

Abstract

Background: There is some consensus that malaria in pregnancy may negatively affect infant's mortality and malaria morbidity, but there is less evidence concerning the factors involved.

Methods: A total of 1030 Mozambican pregnant women were enrolled in a randomized, placebo-controlled trial of intermittent preventive treatment with sulfadoxine-pyrimethamine, and their infants were followed up throughout infancy. Overall mortality and malaria morbidity rates were recorded. The association of maternal and fetal risk factors with infant mortality and malaria morbidity was assessed.

Results: There were 58 infant deaths among 997 live-born infants. The risk of dying during infancy was increased among infants born to women with acute placental infection (odds ratio [OR], 5.08 [95% confidence interval (CI), 1.77-14.53)], parasitemia in cord blood (OR, 19.31 [95% CI, 4.44-84.02]), low birth weight (OR, 2.82 [95% CI, 1.27-6.28]) or prematurity (OR, 3.19 [95% CI, 1.14-8.95]). Infants born to women who had clinical malaria during pregnancy (OR, 1.96 [95% CI, 1.13-3.41]) or acute placental infection (OR, 4.63 [95% CI, 2.10-10.24]) had an increased risk of clinical malaria during infancy.

Conclusions: Malaria infection at the end of pregnancy and maternal clinical malaria negatively impact survival and malaria morbidity in infancy. Effective clinical management and prevention of malaria in pregnancy may improve infant's health and survival.

Trial registration: ClinicalTrials.gov NCT00209781.

Figures

Figure 1.
Figure 1.
Time to first or only clinical malaria episode in infants born to women with placental malaria compared with those born to women without placental malaria, by parity. Infants born to women of all parities (A), primigravid women (B), women with 1–3 previous pregnancies (C), and women with ≥4 previous pregnancies (D). P values adjusted by season: <.001 (primigravid women), .014 (1–3 previous pregnancies), <.001 (≥4 pregnancies), and <.001 (all gravidities). P values adjusted by previous malaria episodes during pregnancy: .002 (primigravid women), <.026 (1–3 previous pregnancies), <.001 (≥4 pregnancies), and <.001 (all gravidities).

References

    1. United Nations. The Millennium Development Goals report. 2010
    1. Statistical Annex. United Nations. The Millennium Development Goals report. 2009 MDG Indicators Database.
    1. Hamer DH, Mwanakasale V, Macleod WB, et al. Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women. J Infect Dis. 2007;196:1585–94.
    1. Black RE, Morris SS, Bryce J. Where and why are 10 million children dying every year? Lancet. 2003;361:2226–34.
    1. Bryce J, Boschi-Pinto C, Shibuya K, Black RE. WHO estimates of the causes of death in children. Lancet. 2005;365:1147–52.
    1. Sacarlal J, Nhacolo AQ, Sigauque B, et al. A 10 year study of the cause of death in children under 15 years in Manhica, Mozambique. BMC Public Health. 2009;9:67.
    1. Abdullah S, Adazu K, Masanja H, et al. Patterns of age-specific mortality in children in endemic areas of sub-Saharan Africa. Am J Trop Med Hyg. 2007;77:99–105.
    1. Greenwood BM, Greenwood AM, Snow RW, Byass P, Bennett S, Hatib-N'Jie AB. The effects of malaria chemoprophylaxis given by traditional birth attendants on the course and outcome of pregnancy. Trans R Soc Trop Med Hyg. 1989;83:589–94.
    1. Brabin B. An assessment of low birthweight risk in primiparae as an indicator of malaria control in pregnancy. Int J Epidemiol. 1991;20:276–83.
    1. Menendez C, Ordi J, Ismail MR, et al. The impact of placental malaria on gestational age and birth weight. J Infect Dis. 2000;181:1740–5.
    1. Romagosa C, Ordi J, Saute F, et al. Seasonal variations in maternal mortality in Maputo, Mozambique: the role of malaria. Trop Med Int Health. 2007;12:62–7.
    1. Steketee RW, Nahlen BL, Parise ME, Menendez C. The burden of malaria in pregnancy in malaria-endemic areas. Am J Trop Med Hyg. 2001;64:28–35.
    1. Greenwood AM, Armstrong JR, Byass P, Snow RW, Greenwood BM. Malaria chemoprophylaxis, birth weight and child survival. Trans R Soc Trop Med Hyg. 1992;86:483–5.
    1. Luxemburger C, McGready R, Kham A, et al. Effects of malaria during pregnancy on infant mortality in an area of low malaria transmission. Am J Epidemiol. 2001;154:459–65.
    1. Haghdoost AA, Alexander N, Smith T. Maternal malaria during pregnancy and infant mortality rate: critical literature review and a new analytical approach. J Vector Borne Dis. 2007;44:98–104.
    1. Brahmbhatt H, Sullivan D, Kigozi G, et al. Association of HIV and malaria with mother-to-child transmission, birth outcomes, and child mortality. J Acquir Immune Defic Syndr. 2008;47:472–6.
    1. van Eijk AM, Ayisi JG, Ter Kuile FO, et al. HIV, malaria, and infant anemia as risk factors for postneonatal infant mortality among HIV-seropositive women in Kisumu, Kenya. J Infect Dis. 2007;196:30–7.
    1. Nyirjesy P, Kavasya T, Axelrod P, Fischer PR. Malaria during pregnancy: neonatal morbidity and mortality and the efficacy of chloroquine chemoprophylaxis. Clin Infect Dis. 1993;16:127–32.
    1. Bloland PB, Wirima JJ, Steketee RW, Chilima B, Hightower A, Breman JG. Maternal HIV infection and infant mortality in Malawi: evidence for increased mortality due to placental malaria infection. AIDS. 1995;9:721–6.
    1. Verhoeff FH, Le Cessie S, Kalanda BF, Kazembe PN, Broadhead RL, Brabin BJ. Post-neonatal infant mortality in Malawi: the importance of maternal health. Ann Trop Paediatr. 2004;24:161–9.
    1. Le Hesran JY, Cot M, Personne P, et al. Maternal placental infection with Plasmodium falciparum and malaria morbidity during the first 2 years of life. Am J Epidemiol. 1997;146:826–31.
    1. Mutabingwa TK. Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy! Acta Trop. 2005;95:305–15.
    1. Schwarz NG, Adegnika AA, Breitling LP, et al. Placental malaria increases malaria risk in the first 30 months of life. Clin Infect Dis. 2008;47:1017–25.
    1. Malhotra I, Dent A, Mungai P, et al. Can prenatal malaria exposure produce an immune tolerant phenotype? A prospective birth cohort study in Kenya. PLoS Med. 2009;6:e1000116.
    1. Alonso PLSF, Aponte JJ, Gómez-Olivé FX, et al. Population and health in developing countries. Vol 1. Population, health, and survival at INDEPTH sites. 1st ed. Ottawa, Ontario: International Development Research Centre; 2002. Mozambique. In INDEPTH; pp. 189–95.
    1. Aranda C, Aponte JJ, Saute F, et al. Entomological characteristics of malaria transmission in Manhica, a rural area in southern Mozambique. J Med Entomol. 2005;42:180–6.
    1. Alonso PL, Sacarlal J, Aponte JJ, et al. Efficacy of the RTS, S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Lancet. 2004;364:1411–20.
    1. Nhacolo AQ, Nhalungo DA, Sacoor CN, Aponte JJ, Thompson R, Alonso P. Levels and trends of demographic indices in southern rural Mozambique: evidence from demographic surveillance in Manhica district. BMC Public Health. 2006;6:291.
    1. Documento estrategico para o controlo e combate da Malaria em Moçambique, 2006- 2009. Programa Nacional de Controlo de Malaria. Ministerio da Saúde de Moçambique Maputo, 2006
    1. Programa Nacional de Controlo de ITS/HIV/SIDA. Plano estratégico nacional de combate às ITS/HIV/SIDA do Ministério da Saúde 2004-2008. Maputo, Mozambique: Ministério da Saúde; 2004.
    1. Menendez C, Bardaji A, Sigauque B, et al. A randomized placebo-controlled trial of intermittent preventive treatment in pregnant women in the context of insecticide treated nets delivered through the antenatal clinic. PLoS ONE. 2008;3:e1934.
    1. Guinovart C, Bassat Q, Sigauque B, et al. Malaria in rural Mozambique. I. Children attending the outpatient clinic. Malar J. 2008;7:36.
    1. Alonso PL, Smith T, Schellenberg JR, et al. Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania. Lancet. 1994;344:1175–81.
    1. Ordi J, Ismail MR, Ventura PJ, et al. Massive chronic intervillositis of the placenta associated with malaria infection. Am J Surg Pathol. 1998;22:1006–11.
    1. Rogerson SJ, Mkundika P, Kanjala MK. Diagnosis of Plasmodium falciparum malaria at delivery: comparison of blood film preparation methods and of blood films with histology. J Clin Microbiol. 2003;41:1370–4.
    1. Ismail MR, Ordi J, Menendez C, et al. Placental pathology in malaria: a histological, immunohistochemical, and quantitative study. Hum Pathol. 2000;31:85–93.
    1. Mutabingwa TK, Bolla MC, Li JL, et al. Maternal malaria and gravidity interact to modify infant susceptibility to malaria. PLoS Med. 2005;2:e407.
    1. Menendez C, Bardaji A, Sigauque B, et al. Malaria prevention with IPTp during pregnancy reduces neonatal mortality. PLoS ONE. 5:e9438.
    1. Duffy PE, Fried M, editors. Malaria in pregnancy: deadly parasite, susceptible host. New York, Taylor & Francis: 2001. pp. 70–126.
    1. Brabin BJ, Romagosa C, Abdelgalil S, et al. The sick placenta-the role of malaria. Placenta. 2004;25:359–78.
    1. Brabin BJ, Fletcher KA, Brown N. Do disturbances within the folate pathway contribute to low birth weight in malaria? Trends Parasitol. 2003;19:39–43.
    1. de Moraes-Pinto MI, Verhoeff F, Chimsuku L, et al. Placental antibody transfer: influence of maternal HIV infection and placental malaria. Arch Dis Child Fetal Neonatal Ed. 1998;79:F202–5.
    1. Brair ME, Brabin BJ, Milligan P, Maxwell S, Hart CA. Reduced transfer of tetanus antibodies with placental malaria. Lancet. 1994;343:208–9.
    1. O'Dempsey TJ, McArdle TF, Lloyd-Evans N, et al. Pneumococcal disease among children in a rural area of west Africa. Pediatr Infect Dis J. 1996;15:431–7.
    1. Riley EM, Wagner GE, Akanmori BD, Koram KA. Do maternally acquired antibodies protect infants from malaria infection? Parasite Immunol. 2001;23:51–9.
    1. Brabin B. Fetal anaemia in malarious areas: its causes and significance. Ann Trop Paediatr. 1992;12:303–10.
    1. Ndyomugyenyi R, Magnussen P. Chloroquine prophylaxis, iron/folic-acid supplementation or case management of malaria attacks in primigravidae in western Uganda: effects on congenital malaria and infant haemoglobin concentrations. Ann Trop Med Parasitol. 2000;94:759–68. discussion 769–70.
    1. Menendez C, Mayor A. Congenital malaria: the least known consequence of malaria in pregnancy. Semin Fetal Neonatal Med. 2007;12:207–13.
    1. Rasheed FN. Maternal infections influence infection susceptibility in childhood. Med Hypotheses. 1994;42:76–80.
    1. Naniche D, Lahuerta M, Bardaji A, et al. Mother-to-child transmission of HIV-1: association with malaria prevention, anaemia and placental malaria. HIV Med. 2008;9:757–64.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever